Clinical Trial Update: Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma [Phase 2]

View source ↗

Summary

This Phase 2 dose-finding study evaluates the tolerability and effect on intraocular pressure of SYL040012 in people with ocular hypertension or open-angle glau…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• SYL040012

Snippet

Sponsor: Sylentis, S.A. | Conditions: Ocular Hypertension, Open Angle Glaucoma | Phase 2 | Status: COMPLETED